Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>CMBI Keeps Buy on BYD COMPANY; Overseas Biz & R&D Capitalization Support Earnings Resilience
Recommend 9 Positive 16 Negative 6 |
||||
|
||||
|
BYD COMPANY (01211.HK) reported 1Q26 revenue and gross margin above expectations on the strength of its overseas business, CMBI released a research report saying. During the period, BYD COMPANY's sales volume and revenue declined by 30% and 12% YoY, respectively, 13% higher than the broker's previous forecasts. R&D expense control was stricter than expected, but foreign exchange losses were higher than anticipated. As a result, net profit in 1Q26 reached RMB4.1 billion, about RMB700 million above the broker's forecast. In CMBI's estimation, BYD COMPANY's 1Q26 R&D capitalization ratio increasing to about 17% from 9% in 2025 was another reason for the forecast-beating net profit. CMBI has kept a Buy rating on BYD COMPANY, with a target price of HKD125. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
